The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bisoprolol Fumarate Market Research Report 2024
Synopsis
Bisoprolol Fumarate is the fumarate salt of a synthetic phenoxy-2-propanol-derived cardioselective beta-1 adrenergic receptor antagonist with antihypertensive and potential cardioprotective activities. Devoid of intrinsic sympathomimetic activity, bisoprolol selectively and competitively binds to and blocks beta-1 adrenergic receptors in the heart, decreasing cardiac contractility and rate, reducing cardiac output, and lowering blood pressure. In addition, this agent may exhibit antihypertensive activity through the inhibition of renin secretion by juxtaglomerular epithelioid (JGE) cells in the kidney, thus inhibiting activation of the renin-angiotensin system (RAS). Bisoprolol has been shown to be cardioprotective in animal models.
The global Bisoprolol Fumarate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bisoprolol Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bisoprolol Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bisoprolol Fumarate include Merck & Co Inc, Intaspharma, Taj Pharma, Jincheng Taier, Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd., Chengdu Easton Biopharmaceuticals Co., Ltd., The Yueyang Xinhua Pharmaceutical Co., Ltd. and Wellso Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bisoprolol Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bisoprolol Fumarate.
Report Scope
The Bisoprolol Fumarate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bisoprolol Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bisoprolol Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co Inc
Intaspharma
Taj Pharma
Jincheng Taier
Yangtze River Pharmaceutical (Group) Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Chengdu Easton Biopharmaceuticals Co., Ltd.
The Yueyang Xinhua Pharmaceutical Co., Ltd.
Wellso Pharmaceutical
Segment by Type
Bisoprolol Fumarate Tablets
Bisoprolol Fumarate Capsules
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bisoprolol Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bisoprolol Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bisoprolol Fumarate is the fumarate salt of a synthetic phenoxy-2-propanol-derived cardioselective beta-1 adrenergic receptor antagonist with antihypertensive and potential cardioprotective activities. Devoid of intrinsic sympathomimetic activity, bisoprolol selectively and competitively binds to and blocks beta-1 adrenergic receptors in the heart, decreasing cardiac contractility and rate, reducing cardiac output, and lowering blood pressure. In addition, this agent may exhibit antihypertensive activity through the inhibition of renin secretion by juxtaglomerular epithelioid (JGE) cells in the kidney, thus inhibiting activation of the renin-angiotensin system (RAS). Bisoprolol has been shown to be cardioprotective in animal models.
The global Bisoprolol Fumarate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bisoprolol Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bisoprolol Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bisoprolol Fumarate include Merck & Co Inc, Intaspharma, Taj Pharma, Jincheng Taier, Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd., Chengdu Easton Biopharmaceuticals Co., Ltd., The Yueyang Xinhua Pharmaceutical Co., Ltd. and Wellso Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bisoprolol Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bisoprolol Fumarate.
Report Scope
The Bisoprolol Fumarate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bisoprolol Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bisoprolol Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co Inc
Intaspharma
Taj Pharma
Jincheng Taier
Yangtze River Pharmaceutical (Group) Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Chengdu Easton Biopharmaceuticals Co., Ltd.
The Yueyang Xinhua Pharmaceutical Co., Ltd.
Wellso Pharmaceutical
Segment by Type
Bisoprolol Fumarate Tablets
Bisoprolol Fumarate Capsules
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bisoprolol Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bisoprolol Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bisoprolol Fumarate Market Overview
1.1 Product Overview and Scope of Bisoprolol Fumarate
1.2 Bisoprolol Fumarate Segment by Type
1.2.1 Global Bisoprolol Fumarate Market Value Comparison by Type (2024-2030)
1.2.2 Bisoprolol Fumarate Tablets
1.2.3 Bisoprolol Fumarate Capsules
1.3 Bisoprolol Fumarate Segment by Application
1.3.1 Global Bisoprolol Fumarate Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Bisoprolol Fumarate Market Size Estimates and Forecasts
1.4.1 Global Bisoprolol Fumarate Revenue 2019-2030
1.4.2 Global Bisoprolol Fumarate Sales 2019-2030
1.4.3 Global Bisoprolol Fumarate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bisoprolol Fumarate Market Competition by Manufacturers
2.1 Global Bisoprolol Fumarate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bisoprolol Fumarate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bisoprolol Fumarate Average Price by Manufacturers (2019-2024)
2.4 Global Bisoprolol Fumarate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bisoprolol Fumarate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bisoprolol Fumarate, Product Type & Application
2.7 Bisoprolol Fumarate Market Competitive Situation and Trends
2.7.1 Bisoprolol Fumarate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bisoprolol Fumarate Players Market Share by Revenue
2.7.3 Global Bisoprolol Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bisoprolol Fumarate Retrospective Market Scenario by Region
3.1 Global Bisoprolol Fumarate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bisoprolol Fumarate Global Bisoprolol Fumarate Sales by Region: 2019-2030
3.2.1 Global Bisoprolol Fumarate Sales by Region: 2019-2024
3.2.2 Global Bisoprolol Fumarate Sales by Region: 2025-2030
3.3 Global Bisoprolol Fumarate Global Bisoprolol Fumarate Revenue by Region: 2019-2030
3.3.1 Global Bisoprolol Fumarate Revenue by Region: 2019-2024
3.3.2 Global Bisoprolol Fumarate Revenue by Region: 2025-2030
3.4 North America Bisoprolol Fumarate Market Facts & Figures by Country
3.4.1 North America Bisoprolol Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bisoprolol Fumarate Sales by Country (2019-2030)
3.4.3 North America Bisoprolol Fumarate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bisoprolol Fumarate Market Facts & Figures by Country
3.5.1 Europe Bisoprolol Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bisoprolol Fumarate Sales by Country (2019-2030)
3.5.3 Europe Bisoprolol Fumarate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bisoprolol Fumarate Market Facts & Figures by Country
3.6.1 Asia Pacific Bisoprolol Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bisoprolol Fumarate Sales by Country (2019-2030)
3.6.3 Asia Pacific Bisoprolol Fumarate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bisoprolol Fumarate Market Facts & Figures by Country
3.7.1 Latin America Bisoprolol Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bisoprolol Fumarate Sales by Country (2019-2030)
3.7.3 Latin America Bisoprolol Fumarate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bisoprolol Fumarate Market Facts & Figures by Country
3.8.1 Middle East and Africa Bisoprolol Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bisoprolol Fumarate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bisoprolol Fumarate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bisoprolol Fumarate Sales by Type (2019-2030)
4.1.1 Global Bisoprolol Fumarate Sales by Type (2019-2024)
4.1.2 Global Bisoprolol Fumarate Sales by Type (2025-2030)
4.1.3 Global Bisoprolol Fumarate Sales Market Share by Type (2019-2030)
4.2 Global Bisoprolol Fumarate Revenue by Type (2019-2030)
4.2.1 Global Bisoprolol Fumarate Revenue by Type (2019-2024)
4.2.2 Global Bisoprolol Fumarate Revenue by Type (2025-2030)
4.2.3 Global Bisoprolol Fumarate Revenue Market Share by Type (2019-2030)
4.3 Global Bisoprolol Fumarate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bisoprolol Fumarate Sales by Application (2019-2030)
5.1.1 Global Bisoprolol Fumarate Sales by Application (2019-2024)
5.1.2 Global Bisoprolol Fumarate Sales by Application (2025-2030)
5.1.3 Global Bisoprolol Fumarate Sales Market Share by Application (2019-2030)
5.2 Global Bisoprolol Fumarate Revenue by Application (2019-2030)
5.2.1 Global Bisoprolol Fumarate Revenue by Application (2019-2024)
5.2.2 Global Bisoprolol Fumarate Revenue by Application (2025-2030)
5.2.3 Global Bisoprolol Fumarate Revenue Market Share by Application (2019-2030)
5.3 Global Bisoprolol Fumarate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck & Co Inc
6.1.1 Merck & Co Inc Corporation Information
6.1.2 Merck & Co Inc Description and Business Overview
6.1.3 Merck & Co Inc Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck & Co Inc Bisoprolol Fumarate Product Portfolio
6.1.5 Merck & Co Inc Recent Developments/Updates
6.2 Intaspharma
6.2.1 Intaspharma Corporation Information
6.2.2 Intaspharma Description and Business Overview
6.2.3 Intaspharma Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Intaspharma Bisoprolol Fumarate Product Portfolio
6.2.5 Intaspharma Recent Developments/Updates
6.3 Taj Pharma
6.3.1 Taj Pharma Corporation Information
6.3.2 Taj Pharma Description and Business Overview
6.3.3 Taj Pharma Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taj Pharma Bisoprolol Fumarate Product Portfolio
6.3.5 Taj Pharma Recent Developments/Updates
6.4 Jincheng Taier
6.4.1 Jincheng Taier Corporation Information
6.4.2 Jincheng Taier Description and Business Overview
6.4.3 Jincheng Taier Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jincheng Taier Bisoprolol Fumarate Product Portfolio
6.4.5 Jincheng Taier Recent Developments/Updates
6.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Product Portfolio
6.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.6 Jiangsu Simcere Pharmaceutical Co., Ltd.
6.6.1 Jiangsu Simcere Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Jiangsu Simcere Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product Portfolio
6.6.5 Jiangsu Simcere Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Chengdu Easton Biopharmaceuticals Co., Ltd.
6.6.1 Chengdu Easton Biopharmaceuticals Co., Ltd. Corporation Information
6.6.2 Chengdu Easton Biopharmaceuticals Co., Ltd. Description and Business Overview
6.6.3 Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Product Portfolio
6.7.5 Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments/Updates
6.8 The Yueyang Xinhua Pharmaceutical Co., Ltd.
6.8.1 The Yueyang Xinhua Pharmaceutical Co., Ltd. Corporation Information
6.8.2 The Yueyang Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product Portfolio
6.8.5 The Yueyang Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Wellso Pharmaceutical
6.9.1 Wellso Pharmaceutical Corporation Information
6.9.2 Wellso Pharmaceutical Description and Business Overview
6.9.3 Wellso Pharmaceutical Bisoprolol Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wellso Pharmaceutical Bisoprolol Fumarate Product Portfolio
6.9.5 Wellso Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bisoprolol Fumarate Industry Chain Analysis
7.2 Bisoprolol Fumarate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bisoprolol Fumarate Production Mode & Process
7.4 Bisoprolol Fumarate Sales and Marketing
7.4.1 Bisoprolol Fumarate Sales Channels
7.4.2 Bisoprolol Fumarate Distributors
7.5 Bisoprolol Fumarate Customers
8 Bisoprolol Fumarate Market Dynamics
8.1 Bisoprolol Fumarate Industry Trends
8.2 Bisoprolol Fumarate Market Drivers
8.3 Bisoprolol Fumarate Market Challenges
8.4 Bisoprolol Fumarate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bisoprolol Fumarate Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bisoprolol Fumarate Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bisoprolol Fumarate Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bisoprolol Fumarate Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bisoprolol Fumarate Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bisoprolol Fumarate Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bisoprolol Fumarate Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bisoprolol Fumarate Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bisoprolol Fumarate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bisoprolol Fumarate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bisoprolol Fumarate, Product Type & Application
Table 12. Global Key Manufacturers of Bisoprolol Fumarate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bisoprolol Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bisoprolol Fumarate as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bisoprolol Fumarate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bisoprolol Fumarate Sales by Region (2019-2024) & (K Units)
Table 18. Global Bisoprolol Fumarate Sales Market Share by Region (2019-2024)
Table 19. Global Bisoprolol Fumarate Sales by Region (2025-2030) & (K Units)
Table 20. Global Bisoprolol Fumarate Sales Market Share by Region (2025-2030)
Table 21. Global Bisoprolol Fumarate Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bisoprolol Fumarate Revenue Market Share by Region (2019-2024)
Table 23. Global Bisoprolol Fumarate Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bisoprolol Fumarate Revenue Market Share by Region (2025-2030)
Table 25. North America Bisoprolol Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bisoprolol Fumarate Sales by Country (2019-2024) & (K Units)
Table 27. North America Bisoprolol Fumarate Sales by Country (2025-2030) & (K Units)
Table 28. North America Bisoprolol Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bisoprolol Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bisoprolol Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bisoprolol Fumarate Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bisoprolol Fumarate Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bisoprolol Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bisoprolol Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bisoprolol Fumarate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bisoprolol Fumarate Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bisoprolol Fumarate Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bisoprolol Fumarate Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bisoprolol Fumarate Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bisoprolol Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bisoprolol Fumarate Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bisoprolol Fumarate Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bisoprolol Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bisoprolol Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bisoprolol Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bisoprolol Fumarate Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Bisoprolol Fumarate Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Bisoprolol Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bisoprolol Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bisoprolol Fumarate Sales (K Units) by Type (2019-2024)
Table 51. Global Bisoprolol Fumarate Sales (K Units) by Type (2025-2030)
Table 52. Global Bisoprolol Fumarate Sales Market Share by Type (2019-2024)
Table 53. Global Bisoprolol Fumarate Sales Market Share by Type (2025-2030)
Table 54. Global Bisoprolol Fumarate Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bisoprolol Fumarate Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bisoprolol Fumarate Revenue Market Share by Type (2019-2024)
Table 57. Global Bisoprolol Fumarate Revenue Market Share by Type (2025-2030)
Table 58. Global Bisoprolol Fumarate Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bisoprolol Fumarate Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bisoprolol Fumarate Sales (K Units) by Application (2019-2024)
Table 61. Global Bisoprolol Fumarate Sales (K Units) by Application (2025-2030)
Table 62. Global Bisoprolol Fumarate Sales Market Share by Application (2019-2024)
Table 63. Global Bisoprolol Fumarate Sales Market Share by Application (2025-2030)
Table 64. Global Bisoprolol Fumarate Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bisoprolol Fumarate Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bisoprolol Fumarate Revenue Market Share by Application (2019-2024)
Table 67. Global Bisoprolol Fumarate Revenue Market Share by Application (2025-2030)
Table 68. Global Bisoprolol Fumarate Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bisoprolol Fumarate Price (US$/Unit) by Application (2025-2030)
Table 70. Merck & Co Inc Corporation Information
Table 71. Merck & Co Inc Description and Business Overview
Table 72. Merck & Co Inc Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck & Co Inc Bisoprolol Fumarate Product
Table 74. Merck & Co Inc Recent Developments/Updates
Table 75. Intaspharma Corporation Information
Table 76. Intaspharma Description and Business Overview
Table 77. Intaspharma Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Intaspharma Bisoprolol Fumarate Product
Table 79. Intaspharma Recent Developments/Updates
Table 80. Taj Pharma Corporation Information
Table 81. Taj Pharma Description and Business Overview
Table 82. Taj Pharma Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Taj Pharma Bisoprolol Fumarate Product
Table 84. Taj Pharma Recent Developments/Updates
Table 85. Jincheng Taier Corporation Information
Table 86. Jincheng Taier Description and Business Overview
Table 87. Jincheng Taier Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Jincheng Taier Bisoprolol Fumarate Product
Table 89. Jincheng Taier Recent Developments/Updates
Table 90. Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 91. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 92. Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Yangtze River Pharmaceutical (Group) Co., Ltd. Bisoprolol Fumarate Product
Table 94. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 95. Jiangsu Simcere Pharmaceutical Co., Ltd. Corporation Information
Table 96. Jiangsu Simcere Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Jiangsu Simcere Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product
Table 99. Jiangsu Simcere Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Chengdu Easton Biopharmaceuticals Co., Ltd. Corporation Information
Table 101. Chengdu Easton Biopharmaceuticals Co., Ltd. Description and Business Overview
Table 102. Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Chengdu Easton Biopharmaceuticals Co., Ltd. Bisoprolol Fumarate Product
Table 104. Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments/Updates
Table 105. The Yueyang Xinhua Pharmaceutical Co., Ltd. Corporation Information
Table 106. The Yueyang Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. The Yueyang Xinhua Pharmaceutical Co., Ltd. Bisoprolol Fumarate Product
Table 109. The Yueyang Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Wellso Pharmaceutical Corporation Information
Table 111. Wellso Pharmaceutical Description and Business Overview
Table 112. Wellso Pharmaceutical Bisoprolol Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Wellso Pharmaceutical Bisoprolol Fumarate Product
Table 114. Wellso Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Bisoprolol Fumarate Distributors List
Table 118. Bisoprolol Fumarate Customers List
Table 119. Bisoprolol Fumarate Market Trends
Table 120. Bisoprolol Fumarate Market Drivers
Table 121. Bisoprolol Fumarate Market Challenges
Table 122. Bisoprolol Fumarate Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bisoprolol Fumarate
Figure 2. Global Bisoprolol Fumarate Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bisoprolol Fumarate Market Share by Type in 2023 & 2030
Figure 4. Bisoprolol Fumarate Tablets Product Picture
Figure 5. Bisoprolol Fumarate Capsules Product Picture
Figure 6. Global Bisoprolol Fumarate Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Bisoprolol Fumarate Market Share by Application in 2023 & 2030
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Others
Figure 12. Global Bisoprolol Fumarate Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Bisoprolol Fumarate Market Size (2019-2030) & (US$ Million)
Figure 14. Global Bisoprolol Fumarate Sales (2019-2030) & (K Units)
Figure 15. Global Bisoprolol Fumarate Average Price (US$/Unit) & (2019-2030)
Figure 16. Bisoprolol Fumarate Report Years Considered
Figure 17. Bisoprolol Fumarate Sales Share by Manufacturers in 2023
Figure 18. Global Bisoprolol Fumarate Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Bisoprolol Fumarate Players: Market Share by Revenue in 2023
Figure 20. Bisoprolol Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Bisoprolol Fumarate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Bisoprolol Fumarate Sales Market Share by Country (2019-2030)
Figure 23. North America Bisoprolol Fumarate Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Bisoprolol Fumarate Sales Market Share by Country (2019-2030)
Figure 27. Europe Bisoprolol Fumarate Revenue Market Share by Country (2019-2030)
Figure 28. Germany Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Bisoprolol Fumarate Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Bisoprolol Fumarate Revenue Market Share by Region (2019-2030)
Figure 35. China Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Bisoprolol Fumarate Sales Market Share by Country (2019-2030)
Figure 46. Latin America Bisoprolol Fumarate Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Bisoprolol Fumarate Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Bisoprolol Fumarate Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Bisoprolol Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Bisoprolol Fumarate by Type (2019-2030)
Figure 56. Global Revenue Market Share of Bisoprolol Fumarate by Type (2019-2030)
Figure 57. Global Bisoprolol Fumarate Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Bisoprolol Fumarate by Application (2019-2030)
Figure 59. Global Revenue Market Share of Bisoprolol Fumarate by Application (2019-2030)
Figure 60. Global Bisoprolol Fumarate Price (US$/Unit) by Application (2019-2030)
Figure 61. Bisoprolol Fumarate Value Chain
Figure 62. Bisoprolol Fumarate Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
